This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
Settings
This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.
This is a web analytics service.
Processing company
  • Google Ireland Limited
  • Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.
Processing company
  • Facebook Ireland Limited
  • 4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland
Data Purposes
  • advertising
  • Marketing
  • Retargeting
  • Analyse
  • Tracking
Technologies Used
  • Cookies
Data Attributes
  • Pixel specific data
  • Http-Header
  • Optional Parameters
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • Facebook user ID
  • Browser information
  • Usage data
  • Geräteinformationen
  • Non-sensitive custom data
  • Referrer URL
  • Pixel ID
  • Location information
  • Pixel specific data
  • User behaviour
  • Ads viewed
  • Interactions with advertisement, services, and products
  • Marketing information
  • Content viewed
  • IP address
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 para. 1 s. 1 lit. a GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Facebook Inc.
This is a web analytics service.
Processing company
  • Zoom Analytics Ltd.
  • Petah Tikva, Israel
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
How Medicines Used to be Produced in Serbia
24. June 2015.
Kurir, 24/06/2015

Hemofarm turned 55 several days ago. Although, measuring by human life expectancy, it is on the verge of the third age, judging by results, this company is in its prime time.

The first private pharmaceutical production started in Vršac in 1960. Although unusual for Yugoslavia at that time, the young and ambitious pharmacist Nikola Gerdec entered an uncertain private venture.

He led 30 workers in the plant, which was a predecessor of the present time pharmaceutical giant.

It was the time of hippie movement, iron curtain fall, loudspeakers resonated the songs of Đorđe Marjanović and Lola Novaković, and ‘fića’ (Fiat 500) and ‘spaček’ (Citroen Diana) were totally cool. The first medicine produced on a production line was Aminopyrine, the precursor to Midol 100, as we know it today. The beginnings were clumsy, but nobody has given up.

The legend says that the associates of Nikola Gerdec copied the formulations for infusion solutions from colleagues who mixed them manually in the hospitals in Banat. Although financial losses were recorded, the will was nevertheless strong. At the most difficult moment, a decision to build a factory was made in 1973. The first export was achieved during that very year. The eighties were the decade of brilliance. Vršac pharmaceutical factory reached the very top in pharmaceutical industry in the former Yugoslavia.

The dreary nineties demonstrated the full strength of the founding values and the Serbian defiance. The company survived, consolidated, and continued operations. There were also resources for helping community, supporting society and children of employees. In 2006, STADA Group, one of the leading global generic manufacturers, recognized a potential in Hemofarm. It has been investing money in new plants, equipment and human resources.

That giant Hemofarm celebrated its 55th anniversary on 1st June in the position of the Serbian and regional leader, a strategic part of STADA Group, which exports the top-quality medicines to 38 countries worldwide. It became a national economic symbol while taking small but persistent steps. Look at the development path of Hemofarm, the factory that changed four countries together with all of us, survived all our turbulent periods, was privatized, but still remained ours.